A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C

F. Tradati, M. Colombo, P. M. Mannucci, M. G. Rumi, C. De Fazio, G. Gamba, N. Ciavarella, A. Rocino, M. Morfini, A. Scaraggi, E. Taioli

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

To assess the risk factors, natural history, and eligibility for curative treatment of early-detected hepatocellular carcinoma (HCC), 385 hemophiliacs who were treated with blood or plasma derivates for at least 10 years and had persistently elevated aminotransferase values underwent an annual screening with an abdominal ultrasound examination and measurement of the serum alpha-fetoprotein (AFP) level. Of these, 355 had serum antibody to hepatitis C virus (anti-HCV), 29 had anti-HCV and hepatitis B surface antigen (HBsAg), and one had HBsAg alone; 141 had serum antibody to human immunodeficiency virus (anti-HIV). During 48 months of follow-up study, six patients developed HCC. All HCC patients had a HCV-related cirrhosis and had been exposed to HCV risk at a median age of 40 years. All patients had a multicentric tumor, which was not eligible for curative treatment. Univariate analysis showed age, cirrhosis, and baseline AFP levels to be significantly associated with an increased risk of HCC. By multivariate analysis, the risk of HCC was infinite in patients with cirrhosis, 31.0 for those with baseline AFP higher than 11 ng/mL, and 17.9 for those more than 45 years of age. in conclusion, the risk of cancer was greater for patients infected later in life, particularly those with cirrhosis and high AFP. Annual screening of hemophiliacs with ultrasound and AFP fails to identify potentially curable tumors because the diagnosis is made at a late stage of the disease.

Original languageEnglish
Pages (from-to)1173-1177
Number of pages5
JournalBlood
Volume91
Issue number4
Publication statusPublished - Feb 15 1998

Fingerprint

alpha-Fetoproteins
Chronic Hepatitis C
Multicenter Studies
Hepatocellular Carcinoma
Prospective Studies
Fibrosis
Viruses
Hepatitis C Antibodies
Hepatitis B Surface Antigens
Antibodies
Tumors
Screening
Ultrasonics
Serum
Neoplasms
Transaminases
Natural History
Blood
Multivariate Analysis
HIV

ASJC Scopus subject areas

  • Hematology

Cite this

Tradati, F., Colombo, M., Mannucci, P. M., Rumi, M. G., De Fazio, C., Gamba, G., ... Taioli, E. (1998). A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. Blood, 91(4), 1173-1177.

A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. / Tradati, F.; Colombo, M.; Mannucci, P. M.; Rumi, M. G.; De Fazio, C.; Gamba, G.; Ciavarella, N.; Rocino, A.; Morfini, M.; Scaraggi, A.; Taioli, E.

In: Blood, Vol. 91, No. 4, 15.02.1998, p. 1173-1177.

Research output: Contribution to journalArticle

Tradati, F, Colombo, M, Mannucci, PM, Rumi, MG, De Fazio, C, Gamba, G, Ciavarella, N, Rocino, A, Morfini, M, Scaraggi, A & Taioli, E 1998, 'A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C', Blood, vol. 91, no. 4, pp. 1173-1177.
Tradati, F. ; Colombo, M. ; Mannucci, P. M. ; Rumi, M. G. ; De Fazio, C. ; Gamba, G. ; Ciavarella, N. ; Rocino, A. ; Morfini, M. ; Scaraggi, A. ; Taioli, E. / A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. In: Blood. 1998 ; Vol. 91, No. 4. pp. 1173-1177.
@article{86cb11a729e541a7974866bca501ca5e,
title = "A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C",
abstract = "To assess the risk factors, natural history, and eligibility for curative treatment of early-detected hepatocellular carcinoma (HCC), 385 hemophiliacs who were treated with blood or plasma derivates for at least 10 years and had persistently elevated aminotransferase values underwent an annual screening with an abdominal ultrasound examination and measurement of the serum alpha-fetoprotein (AFP) level. Of these, 355 had serum antibody to hepatitis C virus (anti-HCV), 29 had anti-HCV and hepatitis B surface antigen (HBsAg), and one had HBsAg alone; 141 had serum antibody to human immunodeficiency virus (anti-HIV). During 48 months of follow-up study, six patients developed HCC. All HCC patients had a HCV-related cirrhosis and had been exposed to HCV risk at a median age of 40 years. All patients had a multicentric tumor, which was not eligible for curative treatment. Univariate analysis showed age, cirrhosis, and baseline AFP levels to be significantly associated with an increased risk of HCC. By multivariate analysis, the risk of HCC was infinite in patients with cirrhosis, 31.0 for those with baseline AFP higher than 11 ng/mL, and 17.9 for those more than 45 years of age. in conclusion, the risk of cancer was greater for patients infected later in life, particularly those with cirrhosis and high AFP. Annual screening of hemophiliacs with ultrasound and AFP fails to identify potentially curable tumors because the diagnosis is made at a late stage of the disease.",
author = "F. Tradati and M. Colombo and Mannucci, {P. M.} and Rumi, {M. G.} and {De Fazio}, C. and G. Gamba and N. Ciavarella and A. Rocino and M. Morfini and A. Scaraggi and E. Taioli",
year = "1998",
month = "2",
day = "15",
language = "English",
volume = "91",
pages = "1173--1177",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C

AU - Tradati, F.

AU - Colombo, M.

AU - Mannucci, P. M.

AU - Rumi, M. G.

AU - De Fazio, C.

AU - Gamba, G.

AU - Ciavarella, N.

AU - Rocino, A.

AU - Morfini, M.

AU - Scaraggi, A.

AU - Taioli, E.

PY - 1998/2/15

Y1 - 1998/2/15

N2 - To assess the risk factors, natural history, and eligibility for curative treatment of early-detected hepatocellular carcinoma (HCC), 385 hemophiliacs who were treated with blood or plasma derivates for at least 10 years and had persistently elevated aminotransferase values underwent an annual screening with an abdominal ultrasound examination and measurement of the serum alpha-fetoprotein (AFP) level. Of these, 355 had serum antibody to hepatitis C virus (anti-HCV), 29 had anti-HCV and hepatitis B surface antigen (HBsAg), and one had HBsAg alone; 141 had serum antibody to human immunodeficiency virus (anti-HIV). During 48 months of follow-up study, six patients developed HCC. All HCC patients had a HCV-related cirrhosis and had been exposed to HCV risk at a median age of 40 years. All patients had a multicentric tumor, which was not eligible for curative treatment. Univariate analysis showed age, cirrhosis, and baseline AFP levels to be significantly associated with an increased risk of HCC. By multivariate analysis, the risk of HCC was infinite in patients with cirrhosis, 31.0 for those with baseline AFP higher than 11 ng/mL, and 17.9 for those more than 45 years of age. in conclusion, the risk of cancer was greater for patients infected later in life, particularly those with cirrhosis and high AFP. Annual screening of hemophiliacs with ultrasound and AFP fails to identify potentially curable tumors because the diagnosis is made at a late stage of the disease.

AB - To assess the risk factors, natural history, and eligibility for curative treatment of early-detected hepatocellular carcinoma (HCC), 385 hemophiliacs who were treated with blood or plasma derivates for at least 10 years and had persistently elevated aminotransferase values underwent an annual screening with an abdominal ultrasound examination and measurement of the serum alpha-fetoprotein (AFP) level. Of these, 355 had serum antibody to hepatitis C virus (anti-HCV), 29 had anti-HCV and hepatitis B surface antigen (HBsAg), and one had HBsAg alone; 141 had serum antibody to human immunodeficiency virus (anti-HIV). During 48 months of follow-up study, six patients developed HCC. All HCC patients had a HCV-related cirrhosis and had been exposed to HCV risk at a median age of 40 years. All patients had a multicentric tumor, which was not eligible for curative treatment. Univariate analysis showed age, cirrhosis, and baseline AFP levels to be significantly associated with an increased risk of HCC. By multivariate analysis, the risk of HCC was infinite in patients with cirrhosis, 31.0 for those with baseline AFP higher than 11 ng/mL, and 17.9 for those more than 45 years of age. in conclusion, the risk of cancer was greater for patients infected later in life, particularly those with cirrhosis and high AFP. Annual screening of hemophiliacs with ultrasound and AFP fails to identify potentially curable tumors because the diagnosis is made at a late stage of the disease.

UR - http://www.scopus.com/inward/record.url?scp=18744419424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744419424&partnerID=8YFLogxK

M3 - Article

VL - 91

SP - 1173

EP - 1177

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -